These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9185044)

  • 1. PAF antagonists as possible inhibitors of corneal epithelial defects and ulceration.
    Bazan HE; Tao Y
    J Ocul Pharmacol Ther; 1997 Jun; 13(3):277-85. PubMed ID: 9185044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-activating factor enhances urokinase-type plasminogen activator gene expression in corneal epithelium.
    Tao Y; Bazan HE; Bazan NG
    Invest Ophthalmol Vis Sci; 1996 Sep; 37(10):2037-46. PubMed ID: 8814143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Platelet-activating factor (PAF) antagonists].
    Terasawa M
    Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):379-87. PubMed ID: 1850862
    [No Abstract]   [Full Text] [Related]  

  • 4. Motility induced by human immunodeficiency virus-1 Tat on Kaposi's sarcoma cells requires platelet-activating factor synthesis.
    Biancone L; Cantaluppi V; Boccellino M; Bussolati B; Del Sorbo L; Conaldi PG; Albini A; Toniolo A; Camussi G
    Am J Pathol; 1999 Nov; 155(5):1731-9. PubMed ID: 10550329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phospholipid thrombocyte activating factor, its analogs and antagonists: prospects of their use in medicine].
    Kulikov VI; Muzia GI
    Vestn Akad Med Nauk SSSR; 1991; (10):13-7. PubMed ID: 1801455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of platelet-activating factor (PAF) antagonists and nitric oxide in cardiac actions of PAF. Electrophysiological and morphological study.
    Kecskeméti V; Balogh I
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):723-35. PubMed ID: 11192945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-activating factor antagonists decrease the inflammatory nociceptive response in rats.
    Teather LA; Magnusson JE; Wurtman RJ
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):430-3. PubMed ID: 12373444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mitogen-activated protein kinase (MAP-kinase) cascade is stimulated by platelet activating factor (PAF) in corneal epithelium.
    Bazan HE; Varner L
    Curr Eye Res; 1997 Apr; 16(4):372-9. PubMed ID: 9134327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor induces collagenase expression in corneal epithelial cells.
    Bazan HE; Tao Y; Bazan NG
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8678-82. PubMed ID: 8378347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Corneal epithelial wound healing is delayed by platelet activating factor treatment].
    Ma X; Ni CX; Bazan H; Sun HC
    Zhonghua Yan Ke Za Zhi; 2004 Mar; 40(3):151-5. PubMed ID: 15307983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet activating factor (PAF) antagonists on cytokine induction of iNOS and sPLA2 in immortalized astrocytes (DITNC).
    Wang JH; Sun GY
    Neurochem Res; 2000 May; 25(5):613-9. PubMed ID: 10905622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of platelet-activating factor in the corneal response to injury.
    Bazan H; Ottino P
    Prog Retin Eye Res; 2002 Sep; 21(5):449-64. PubMed ID: 12207945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corneal stimulation of MMP-1, -9 and uPA by platelet-activating factor is mediated by cyclooxygenase-2 metabolites.
    Ottino P; Bazan HE
    Curr Eye Res; 2001 Aug; 23(2):77-85. PubMed ID: 11840344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From ginkgolides to N-substituted piperidino-thieno diazepines, a new series of highly potent dual antagonists.
    Braquet P; Laurent JP; Rolland A; Martin C; Pommier J; Hosford D; Esanu A
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():929-37. PubMed ID: 1825436
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet-activating factor induces the expression of metalloproteinases-1 and -9, but not -2 or -3, in the corneal epithelium.
    Tao Y; Bazan HE; Bazan NG
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):345-54. PubMed ID: 7843905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAF antagonism as an approach to the treatment of airway hyperreactivity.
    Meade CJ; Heuer H
    Am Rev Respir Dis; 1991 Mar; 143(3 Pt 2):S79-82. PubMed ID: 2003696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor induces the gene expression of TIMP-1, -2, and PAI-1: imbalance between the gene expression of MMP-9 and TIMP-1 and -2.
    Ottino P; Taheri F; Bazan HE
    Exp Eye Res; 2002 Mar; 74(3):393-402. PubMed ID: 12014920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delay of corneal epithelial wound healing and induction of keratocyte apoptosis by platelet-activating factor.
    Chandrasekher G; Ma X; Lallier TE; Bazan HE
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1422-8. PubMed ID: 11980856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAF-induced amplification of mediator release in septic shock: prevention or downregulation by PAF antagonists.
    Koltai M; Hosford D; Braquet P
    J Lipid Mediat; 1993; 6(1-3):183-98. PubMed ID: 8357981
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelet-activating factor and antagonists modulate DNA synthesis in human bone marrow stromal cell cultures.
    Rougier F; Dupuis F; Cornu E; Dulery C; Praloran V; Denizot Y
    J Lipid Mediat Cell Signal; 1997 Jul; 16(3):147-53. PubMed ID: 9246604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.